Literature DB >> 30947875

Rheumatologic Diseases and the Liver.

Agazi Gebreselassie1, Farshad Aduli2, Charles D Howell3.   

Abstract

A variety of rheumatologic disorders may affect the liver. There is a significant epidemiologic, genetic, and immunologic overlap between immune-mediated rheumatologic disorders and autoimmune liver diseases. There is an increased frequency of autoimmune liver diseases, such as primary biliary cholangitis, autoimmune hepatitis, primary sclerosing cholangitis, or overlap syndrome, in patients with systemic lupus erythematosus, rheumatoid arthritis, Sjögren syndrome, systemic sclerosis, vasculitis, and other immune-related diseases. Non-immune-mediated rheumatologic diseases such as gouty arthritis may also have hepatic manifestations. Furthermore, medications used to treat rheumatologic diseases occasionally cause liver dysfunction. Conversely, primary immune-mediated and non-immune-mediated liver disorders may present with rheumatologic manifestations.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune liver disease; Elevated liver enzymes; Hepatotoxicity; Liver injury; Rheumatologic diseases

Year:  2019        PMID: 30947875     DOI: 10.1016/j.cld.2018.12.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  5 in total

Review 1.  Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies.

Authors:  Deepak M W Balak; Stefano Piaserico; Ismail Kasujee
Journal:  Psoriasis (Auckl)       Date:  2021-12-07

2.  2-Deoxy-D-glucose Alleviates Collagen-Induced Arthritis of Rats and Is Accompanied by Metabolic Regulation of the Spleen and Liver.

Authors:  Hongxing Wang; Nanyang Zhang; Kehua Fang; Xiaotian Chang
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

Review 3.  Autoimmune liver diseases in systemic rheumatic diseases.

Authors:  Chrong-Reen Wang; Hung-Wen Tsai
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

4.  Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis.

Authors:  Hanxiao You; Linyi Peng; Jiuliang Zhao; Yunyun Fei; Qian Wang; Wen Zhang; Mengtao Li; Xiaofeng Zeng
Journal:  J Immunol Res       Date:  2020-05-21       Impact factor: 4.818

5.  The impact of bariatric surgery on in-patient clinical outcomes among patients with autoimmune hepatitis.

Authors:  Catherine Choi; Aldo Barajas-Ochoa; Aditya Uppuluri; Grace Ro; Reza Hashemipour; Yi Jiang; Umair Nasir; Sushil Ahlawat
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.